Table 1 KDM4A-AS1 expression level and main characteristics of the CRPC patients (n = 18).

From: RETRACTED ARTICLE: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Characteristics

n% (n)

KDM4A-AS1 RNAScope score (mean)

P value

Age

<70

27.8% (5)

2

0.5346

≥70

33.3% (6)

1.4

 

Censor

38.9% (7)

  

Smoke history

No

44.5% (8)

1

0.0586

Yes

33.3% (6)

2.25

 

Censor

22.2% (4)

  

Alcohol

No

55.6% (10)

1.33

0.5384

Yes

22.2% (4)

2

 

Censor

22.2% (4)

  

Disease-free survival time

<1 year

22.2% (4)

3.25

0.0119

≥1 year

55.6% (10)

1.3

 

Censor

22.2% (4)

  

Gleason score

<8

16.7% (3)

2.5

0.4592

≥8

83.3% (15)

1.69

 
  1. Significance threshold: P value < 0.05.